FLGT today
$24.66-$0.19 (-0.76%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns down below $13.46
Key levels
Resistance$27.41
Resistance$24.91
Support$21.77
Support$20.34
Latest news & SEC filings
AnalystPiper Sandler keeps Neutral rating on Fulgent Genetics, lifts target to $25
EarningsFulgent Genetics Posts Third-Quarter 2026 Results
All FLGT news →About Fulgent Genetics
Fulgent Genetics operates a lab testing business that covers tissue pathology, advanced diagnostics, gene sequencing, and inherited condition panels spanning cancer risk, fertility, and uncommon disorders. Buyers of these services include insurers, care providers, research and government organizations, companies, and self-paying individuals; drugmakers and biotech firms also purchase testing and license its offerings. A second arm develops oncology drug candidates built on a nanoencapsulation delivery technology. Testing work happens at certified sites throughout the United States.
Based on the company's 10-K filed Feb 27, 2026.
Nasdaq · Healthcare
Fulgent Genetics, Inc. (FLGT)
What Is the Price Target for FLGT?
SEPT Low Target
$15.00
SEPT Mid Target
$17.00
SEPT High Target
$19.00
Analyst Consensus
$17.00
Is FLGT a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for FLGT.
Start Free Trial →Is FLGT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$36.11
36
Moat Score
NONE
3/9
Piotroski Score
4.5
Altman Z-Score
What Is Smart Money Doing with FLGT?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kim Paul | officer | Sale | 2,748 | $56K | Oct 26, 2026 |
| Gao Hanlin | officer | Sale | 1,645 | $33K | Oct 26, 2026 |
| Xie Jian | officer | Sale | 4,361 | $88K | Oct 26, 2026 |
| Kim Paul | officer | Sale | 2,087 | $41K | Sep 1, 2026 |
| Hsieh Ming | director officer 10% owner | Sale | 4,392 | $86K | Sep 1, 2026 |
| Xie Jian | officer | Sale | 1,193 | $24K | Aug 27, 2026 |
| Gao Hanlin | officer | Sale | 939 | $19K | Aug 27, 2026 |
| Hsieh Ming | director officer 10% owner | Sale | 2,949 | $58K | Aug 26, 2026 |
| Kim Paul | officer | Sale | 1,168 | $23K | Aug 26, 2026 |
| Xie Jian | officer | Sale | 2,146 | $38K | Jun 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →FLGT Growth Story
Revenue YoY
13.8%
3yr Revenue CAGR
-19.5%
EPS Growth YoY
-39.72%
FCF Growth YoY
-545.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for FLGT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for FLGT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:32:30 | $24.66 | 1,033 | $$25K | MIDPOINT |
| 21:42:42 | $24.85 | 107,506 | $$2.7M | SELL |
| 21:00:23 | $24.85 | 3,581 | $$89K | SELL |
| 20:59:52 | $24.85 | 1,000 | $$25K | BUY |
| 20:50:31 | $24.68 | 1,000 | $$25K | MIDPOINT |
5 dark pool trades shown · $$2.8M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Fulgent Genetics, Inc. (FLGT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →FLGT — frequently asked questions
What is FLGT stock price today?
Fulgent Genetics, Inc. (FLGT) is at $24.66, down 0.76% (-$0.19) at the Nov 13, 2026 close.
Why is FLGT stock moving today?
Latest FLGT news — Nov 10, 2026: Piper Sandler keeps Neutral rating on Fulgent Genetics, lifts target to $25 · Nov 6, 2026: Fulgent Genetics Posts Third-Quarter 2026 Results
What is the FLGT price target?
The average analyst price target for FLGT is $17.00, ranging from $15 to $19, based on 2 analysts. Latest: Piper Sandler maintains on Aug 4, 2026.
What do analysts rate FLGT?
Analyst ratings for FLGT: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did FLGT beat earnings?
FLGT last reported on Jul 30, 2026: EPS -$0.58 vs -$0.46 expected — a miss of 26.1%.
Does FLGT pay a dividend?
FLGT does not currently pay a dividend.
What are FLGT support and resistance levels?
Support: $21.77, $20.34, $18.44. Resistance: $24.91, $27.41, $28.95.
What are insiders doing with FLGT?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on FLGT?
Nov 10, 2026: Piper Sandler keeps Neutral rating on Fulgent Genetics, lifts target to $25 · Nov 6, 2026: Fulgent Genetics Posts Third-Quarter 2026 Results